Franck Hansmannel

Franck Hansmannel

Auto-generated profile, based on publicly available information

Franck Hansmannel

Inserm U1256 “Nutrition – Genetics and exposure to environmental risks ‐ NGERE” Nancy France

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2020 in United European Gastroenterology Journal
Verified
Journal Article
Open access
PDF file
MMMarie MULLER
Marie MULLER
FHFranck Hansmannel
Franck Hansmannel
DADjesia Arnone
Djesia Arnone
MCMyriam Choukour
Myriam Choukour
NNNdeye Coumba Ndiaye
Ndeye Coumba Ndiaye
Laurent Peyrin-birouletLaurent Peyrin-biroulet
Laurent Peyrin-biroulet
Patients with inflammatory bowel disease are at increased risk of colorectal cancer, which has worse prognosis than sporadic colorectal cancer. Until recently, understanding of pathogenesis in inflammatory bowel disease‐associated colorectal cancer was restricted to the demonstration of chromosomic/microsatellite instabilities and aneuploidy. The advance of high‐throughput sequencing technologies has highlighted the complexity of the pathobiology and revealed recurrently mutated genes involved in the RTK/RAS, PI3K, WNT, and TGFβ pathways, leading to potentially new targetable mutations. Moreover, alterations of mitochondrial DNA and the dysregulation of non‐coding sequences have also been described, as well as several epigenetic modifications. Although recent studies have brought new insights into pathobiology and raised the prospect of innovative therapeutic approaches, the understanding of colorectal carcinogenesis in inflammatory bowel disease and how it differs from sporadic colorectal cancer remains not fully elucidated. Further studies are required to better understand the pathogenesis and molecular alterations leading to human inflammatory bowel disease‐associated colorectal cancer.